934240-31-0

基本信息
(2S,5R)-5-(4-((2-氟芐基)氧基)苯基)吡咯烷-2-甲酰胺鹽酸鹽
(2S,5R)-2-吡咯烷甲酰胺-5-[4-[(2-氟苯基)甲氧基]苯基]鹽酸鹽(1:1)
Raxatrigine HCl
GSK-1014802 HCl
GSK-1014802 hydrochloride
Raxatrigine hydrochloride
CNV1014802 (hydrochloride)
CNV1014802(Raxatrigine) hydrochloride
Raxatrigine hydrochloride(GSK1014802)
Raxatrigine HCl (GSK1014802, CNV1014802)
GSK-1014802
GSK 1014802
CNV-1014802
CNV 1014802
物理化學(xué)性質(zhì)
常見問題列表

934240-30-9

934240-31-0
以(2S,5R)-5-(4-((2-氟芐基)氧基)苯基)吡咯烷-2-甲酰胺(5.46 g,17.37 mmol)為原料,將其溶解于乙酸乙酯(140 mL)中,攪拌30分鐘后過濾。向濾液中加入4M HCl的二惡烷溶液(6.51 mL,26.05 mmol),室溫下攪拌反應(yīng)20分鐘,隨后在冰浴中冷卻15分鐘。通過過濾收集生成的固體,用冷乙酸乙酯(2×20 mL)洗滌,先在35℃下真空干燥過夜,再在50℃下干燥2小時,得到灰白色固體產(chǎn)物(E1,5.87 g,收率96%)。LC-MS顯示MH+ = 315(對應(yīng)分子式C18H19FN2O2)。1H NMR(d6-DMSO)數(shù)據(jù)如下:δ 1.95-2.20(2H,m),2.30(2H,m),3.35(1H,s),4.30(1H,m),4.61(1H,m),5.18(2H,s),7.10(2H,d,J = 9 Hz),7.18-7.30(2H,m),7.40(1H,m),7.47(2H,d,J = 9 Hz),7.56(1H,s),7.72(1H,s),8.07(1H,s),10.60(1H,br s)。
參考文獻:
[1] Patent: WO2016/102967, 2016, A1. Location in patent: Page/Page column 43
[2] Patent: WO2011/29762, 2011, A1. Location in patent: Page/Page column 23-24
[3] Patent: WO2007/42239, 2007, A1. Location in patent: Page/Page column 45
[4] Patent: WO2007/42239, 2007, A1. Location in patent: Page/Page column 45-46
[5] Patent: WO2007/42239, 2007, A1. Location in patent: Page/Page column 46
報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
2025/05/22 | HY-12796A | (2S,5R)-5-(4-((2-氟芐基)氧基)苯基)吡咯烷-2-甲酰胺鹽酸鹽 Raxatrigine hydrochloride | 934240-31-0 | 1 mg | 480元 |
2025/05/22 | HY-12796A | (2S,5R)-5-(4-((2-氟芐基)氧基)苯基)吡咯烷-2-甲酰胺鹽酸鹽 Raxatrigine hydrochloride | 934240-31-0 | 5mg | 1200元 |
2025/05/22 | HY-12796A | (2S,5R)-5-(4-((2-氟芐基)氧基)苯基)吡咯烷-2-甲酰胺鹽酸鹽 Raxatrigine hydrochloride | 934240-31-0 | 10mM * 1mLin DMSO | 1320元 |